Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”

[...]did you do an analysis comparing the Aspirin/Plavix group to the 287 controlled groups that you cite? [...]why did you not match 2-to-1 controls for those Plavix/Aspirin group which is a common way in case control studies to increase the power? Stated another way, were any of the deaths in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgery 2017-12, Vol.214 (6), p.1016-1017
Hauptverfasser: Pearcy, Christopher, Almahmoud, Khalid, Jackson, Theresa, Hartline, Cassie, Cahill, Anthony, Spence, Lara, Kim, Dennis, Olatubosun, Oluwabukola, Todd, S. Rob, Campion, Eric M., Burlew, Clay Cothren, Regner, Justin, Frazee, Richard, Michaels, David, Dissanaike, Sharmila, Stewart, Collin, Foley, Neal, Nelson, Paul, Agrawal, Vaidehi, Truitt, Michael S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1017
container_issue 6
container_start_page 1016
container_title The American journal of surgery
container_volume 214
creator Pearcy, Christopher
Almahmoud, Khalid
Jackson, Theresa
Hartline, Cassie
Cahill, Anthony
Spence, Lara
Kim, Dennis
Olatubosun, Oluwabukola
Todd, S. Rob
Campion, Eric M.
Burlew, Clay Cothren
Regner, Justin
Frazee, Richard
Michaels, David
Dissanaike, Sharmila
Stewart, Collin
Foley, Neal
Nelson, Paul
Agrawal, Vaidehi
Truitt, Michael S.
description [...]did you do an analysis comparing the Aspirin/Plavix group to the 287 controlled groups that you cite? [...]why did you not match 2-to-1 controls for those Plavix/Aspirin group which is a common way in case control studies to increase the power? Stated another way, were any of the deaths in the Plavix/Aspirin group related in any way to postoperative/intraoperative bleeding?
doi_str_mv 10.1016/j.amjsurg.2017.10.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1952526769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961017314162</els_id><sourcerecordid>1965451947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-c98c08795696fac5092efbd81619a1cdfbcccf2c723cd96e4123253a8aafe0f03</originalsourceid><addsrcrecordid>eNqFkctu1DAUhi0EotPCI4AssWGTwXYSJ2ZTVaVApUpICNaW49hTh4kdfKk0u74AbwAv1yfhjGZgwYaV5XO-c_t_hF5QsqaE8jfTWs1TKnGzZoR2EFsTyh6hFe07UdG-rx-jFSGEVYJTcoJOU5rgS2lTP0UnTJCGEdKv0I93LumSkgseB_sWP9z__OzStx0eSnLepHSOr_2dSdltVHZ-g0PJOswmAY0XCBmfEy5-NHET9nnYCEJ4qxYVQ9JhcRqrZTFA6BzmHYZBymeXb2OYh5AhnW9NVMvu4f7XM_TEqm0yz4_vGfr6_urL5cfq5tOH68uLm0rXDc2VFr0mcGfLBbdKt0QwY4exp5wKRfVoB621ZbpjtR4FNw1lNWtr1StlDbGkPkOvD32XGL4XuE7OIIPZbpU3oSRJRctaxjsuAH31DzqFEj1sBxRvm5aKpgOqPVAajk7RWLlEN6u4k5TIvV9ykke_5N6vfRj8grqXx-5lmM34t-qPQQCcHwADctw5E2XSoLk2o4sgqByD-8-I36cpr4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1965451947</pqid></control><display><type>article</type><title>Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pearcy, Christopher ; Almahmoud, Khalid ; Jackson, Theresa ; Hartline, Cassie ; Cahill, Anthony ; Spence, Lara ; Kim, Dennis ; Olatubosun, Oluwabukola ; Todd, S. Rob ; Campion, Eric M. ; Burlew, Clay Cothren ; Regner, Justin ; Frazee, Richard ; Michaels, David ; Dissanaike, Sharmila ; Stewart, Collin ; Foley, Neal ; Nelson, Paul ; Agrawal, Vaidehi ; Truitt, Michael S.</creator><creatorcontrib>Pearcy, Christopher ; Almahmoud, Khalid ; Jackson, Theresa ; Hartline, Cassie ; Cahill, Anthony ; Spence, Lara ; Kim, Dennis ; Olatubosun, Oluwabukola ; Todd, S. Rob ; Campion, Eric M. ; Burlew, Clay Cothren ; Regner, Justin ; Frazee, Richard ; Michaels, David ; Dissanaike, Sharmila ; Stewart, Collin ; Foley, Neal ; Nelson, Paul ; Agrawal, Vaidehi ; Truitt, Michael S.</creatorcontrib><description>[...]did you do an analysis comparing the Aspirin/Plavix group to the 287 controlled groups that you cite? [...]why did you not match 2-to-1 controls for those Plavix/Aspirin group which is a common way in case control studies to increase the power? Stated another way, were any of the deaths in the Plavix/Aspirin group related in any way to postoperative/intraoperative bleeding?</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2017.10.012</identifier><identifier>PMID: 29042008</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Appendectomy ; Appendicitis - surgery ; Aspirin ; Comorbidity ; Fibrinolytic Agents ; Humans ; Laparoscopy ; Length of Stay ; Retrospective Studies ; Treatment Outcome</subject><ispartof>The American journal of surgery, 2017-12, Vol.214 (6), p.1016-1017</ispartof><rights>2017</rights><rights>Copyright Elsevier Limited Dec 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002961017314162$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29042008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pearcy, Christopher</creatorcontrib><creatorcontrib>Almahmoud, Khalid</creatorcontrib><creatorcontrib>Jackson, Theresa</creatorcontrib><creatorcontrib>Hartline, Cassie</creatorcontrib><creatorcontrib>Cahill, Anthony</creatorcontrib><creatorcontrib>Spence, Lara</creatorcontrib><creatorcontrib>Kim, Dennis</creatorcontrib><creatorcontrib>Olatubosun, Oluwabukola</creatorcontrib><creatorcontrib>Todd, S. Rob</creatorcontrib><creatorcontrib>Campion, Eric M.</creatorcontrib><creatorcontrib>Burlew, Clay Cothren</creatorcontrib><creatorcontrib>Regner, Justin</creatorcontrib><creatorcontrib>Frazee, Richard</creatorcontrib><creatorcontrib>Michaels, David</creatorcontrib><creatorcontrib>Dissanaike, Sharmila</creatorcontrib><creatorcontrib>Stewart, Collin</creatorcontrib><creatorcontrib>Foley, Neal</creatorcontrib><creatorcontrib>Nelson, Paul</creatorcontrib><creatorcontrib>Agrawal, Vaidehi</creatorcontrib><creatorcontrib>Truitt, Michael S.</creatorcontrib><title>Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>[...]did you do an analysis comparing the Aspirin/Plavix group to the 287 controlled groups that you cite? [...]why did you not match 2-to-1 controls for those Plavix/Aspirin group which is a common way in case control studies to increase the power? Stated another way, were any of the deaths in the Plavix/Aspirin group related in any way to postoperative/intraoperative bleeding?</description><subject>Appendectomy</subject><subject>Appendicitis - surgery</subject><subject>Aspirin</subject><subject>Comorbidity</subject><subject>Fibrinolytic Agents</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Length of Stay</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkctu1DAUhi0EotPCI4AssWGTwXYSJ2ZTVaVApUpICNaW49hTh4kdfKk0u74AbwAv1yfhjGZgwYaV5XO-c_t_hF5QsqaE8jfTWs1TKnGzZoR2EFsTyh6hFe07UdG-rx-jFSGEVYJTcoJOU5rgS2lTP0UnTJCGEdKv0I93LumSkgseB_sWP9z__OzStx0eSnLepHSOr_2dSdltVHZ-g0PJOswmAY0XCBmfEy5-NHET9nnYCEJ4qxYVQ9JhcRqrZTFA6BzmHYZBymeXb2OYh5AhnW9NVMvu4f7XM_TEqm0yz4_vGfr6_urL5cfq5tOH68uLm0rXDc2VFr0mcGfLBbdKt0QwY4exp5wKRfVoB621ZbpjtR4FNw1lNWtr1StlDbGkPkOvD32XGL4XuE7OIIPZbpU3oSRJRctaxjsuAH31DzqFEj1sBxRvm5aKpgOqPVAajk7RWLlEN6u4k5TIvV9ykke_5N6vfRj8grqXx-5lmM34t-qPQQCcHwADctw5E2XSoLk2o4sgqByD-8-I36cpr4Q</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Pearcy, Christopher</creator><creator>Almahmoud, Khalid</creator><creator>Jackson, Theresa</creator><creator>Hartline, Cassie</creator><creator>Cahill, Anthony</creator><creator>Spence, Lara</creator><creator>Kim, Dennis</creator><creator>Olatubosun, Oluwabukola</creator><creator>Todd, S. Rob</creator><creator>Campion, Eric M.</creator><creator>Burlew, Clay Cothren</creator><creator>Regner, Justin</creator><creator>Frazee, Richard</creator><creator>Michaels, David</creator><creator>Dissanaike, Sharmila</creator><creator>Stewart, Collin</creator><creator>Foley, Neal</creator><creator>Nelson, Paul</creator><creator>Agrawal, Vaidehi</creator><creator>Truitt, Michael S.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201712</creationdate><title>Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”</title><author>Pearcy, Christopher ; Almahmoud, Khalid ; Jackson, Theresa ; Hartline, Cassie ; Cahill, Anthony ; Spence, Lara ; Kim, Dennis ; Olatubosun, Oluwabukola ; Todd, S. Rob ; Campion, Eric M. ; Burlew, Clay Cothren ; Regner, Justin ; Frazee, Richard ; Michaels, David ; Dissanaike, Sharmila ; Stewart, Collin ; Foley, Neal ; Nelson, Paul ; Agrawal, Vaidehi ; Truitt, Michael S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-c98c08795696fac5092efbd81619a1cdfbcccf2c723cd96e4123253a8aafe0f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Appendectomy</topic><topic>Appendicitis - surgery</topic><topic>Aspirin</topic><topic>Comorbidity</topic><topic>Fibrinolytic Agents</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Length of Stay</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pearcy, Christopher</creatorcontrib><creatorcontrib>Almahmoud, Khalid</creatorcontrib><creatorcontrib>Jackson, Theresa</creatorcontrib><creatorcontrib>Hartline, Cassie</creatorcontrib><creatorcontrib>Cahill, Anthony</creatorcontrib><creatorcontrib>Spence, Lara</creatorcontrib><creatorcontrib>Kim, Dennis</creatorcontrib><creatorcontrib>Olatubosun, Oluwabukola</creatorcontrib><creatorcontrib>Todd, S. Rob</creatorcontrib><creatorcontrib>Campion, Eric M.</creatorcontrib><creatorcontrib>Burlew, Clay Cothren</creatorcontrib><creatorcontrib>Regner, Justin</creatorcontrib><creatorcontrib>Frazee, Richard</creatorcontrib><creatorcontrib>Michaels, David</creatorcontrib><creatorcontrib>Dissanaike, Sharmila</creatorcontrib><creatorcontrib>Stewart, Collin</creatorcontrib><creatorcontrib>Foley, Neal</creatorcontrib><creatorcontrib>Nelson, Paul</creatorcontrib><creatorcontrib>Agrawal, Vaidehi</creatorcontrib><creatorcontrib>Truitt, Michael S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pearcy, Christopher</au><au>Almahmoud, Khalid</au><au>Jackson, Theresa</au><au>Hartline, Cassie</au><au>Cahill, Anthony</au><au>Spence, Lara</au><au>Kim, Dennis</au><au>Olatubosun, Oluwabukola</au><au>Todd, S. Rob</au><au>Campion, Eric M.</au><au>Burlew, Clay Cothren</au><au>Regner, Justin</au><au>Frazee, Richard</au><au>Michaels, David</au><au>Dissanaike, Sharmila</au><au>Stewart, Collin</au><au>Foley, Neal</au><au>Nelson, Paul</au><au>Agrawal, Vaidehi</au><au>Truitt, Michael S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2017-12</date><risdate>2017</risdate><volume>214</volume><issue>6</issue><spage>1016</spage><epage>1017</epage><pages>1016-1017</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><abstract>[...]did you do an analysis comparing the Aspirin/Plavix group to the 287 controlled groups that you cite? [...]why did you not match 2-to-1 controls for those Plavix/Aspirin group which is a common way in case control studies to increase the power? Stated another way, were any of the deaths in the Plavix/Aspirin group related in any way to postoperative/intraoperative bleeding?</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29042008</pmid><doi>10.1016/j.amjsurg.2017.10.012</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9610
ispartof The American journal of surgery, 2017-12, Vol.214 (6), p.1016-1017
issn 0002-9610
1879-1883
language eng
recordid cdi_proquest_miscellaneous_1952526769
source MEDLINE; Elsevier ScienceDirect Journals
subjects Appendectomy
Appendicitis - surgery
Aspirin
Comorbidity
Fibrinolytic Agents
Humans
Laparoscopy
Length of Stay
Retrospective Studies
Treatment Outcome
title Discussion of: “Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy”
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A33%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discussion%20of:%20%E2%80%9CRisky%20business?%20Investigating%20outcomes%20of%20patients%20undergoing%20urgent%20laparoscopic%20appendectomy%20on%20antithrombotic%20therapy%E2%80%9D&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Pearcy,%20Christopher&rft.date=2017-12&rft.volume=214&rft.issue=6&rft.spage=1016&rft.epage=1017&rft.pages=1016-1017&rft.issn=0002-9610&rft.eissn=1879-1883&rft_id=info:doi/10.1016/j.amjsurg.2017.10.012&rft_dat=%3Cproquest_cross%3E1965451947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1965451947&rft_id=info:pmid/29042008&rft_els_id=S0002961017314162&rfr_iscdi=true